… energy to the heart to treat atrial fibrillation (AFib). In June 2024, … the US Food and Drug Administration (FDA), the Globe system achieved … make individualised patient‑centred treatment decisions.” Globe PF is … to initiate a pivotal trial of the system this …

"We are delighted to have received FDA Breakthrough Device Designation for AVIM therapy which has the potential to offer a differentiated, advantageous solution for hypertension management in a broad population," commented David Hochman, Chairman …

… ablation catheter for treatment of paroxysmal atrial fibrillation (PAF). … -arm, multi-center trial performed in European centers … technologies and therapies treat 70 health conditions … and management of atrial fibrillation developed in collaboration with …

… the groundbreaking LeAPPS Clinical Trial, an international study aimed … with risk factors for atrial fibrillation and ischemic stroke. This … participate in this essential trial to help reduce stroke … community access top-quality treatment close to home.” By …

… atrial fibrillation symptoms and long episodes of atrial fibrillation (LEAF) FDA … drug.  Patent No. 12,115,373 instructs a physician treating … with anti-arrhythmic drugs (AAD), electrophysiological … company committed to developing innovative therapies for …

… treating ventricular arrhythmia, or irregular heart rhythm, including atrial fibrillation … physicians use the FDA-approved technology to … -invasive procedures to treat atrial and ventricular … develop novel leading-edge technologies to improve treatment …

… where it’s a pharmacoepidemiologic study across the entire … use in the TRANSFORM trial was reported to be … The feasibility of a randomized trial in the way all of … managing obesity along with atrial fibrillation through ablations and drugs ... [and] use …

… multi-center, non-randomized clinical trial that evaluates the safety and … pulsed field ablation (PFA) in atrial fibrillation treatment, particularly for pulmonary vein isolation … information or future events or developments. © Johnson & Johnson and its …

… as adjunctive treatment for persistent atrial fibrillation (AF). The single-arm, prospective trial focused … cavotricuspid isthmus (CTI) ablation to treat typical atrial flutter (AFL). Subjects … is expected to receive the FDA approval for expanded use labelling …

… -controlled, double-blind trial commenced subject enrolment and … products, incidence of new atrial fibrillation cases, and the … potential to transform the treatment landscape of cardiac … complications.” Renibus Therapeutics develops products for preventing the …